$0.1944
-0.0357-15.51%
al cierre: Nov 18, 4:00 PM EST
$0.1975
0.00311.59%
After hour: 4:28 PM EST
Acumen Pharmaceuticals (ABOS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 26, 2026 | $-0.35 | $-0.40 | 12.5 % |
| Q2 | Aug 12, 2026 | $-0.45 | $-0.40 | -12.5 % |
| Q1 | May 12, 2026 | $-0.33 | $-0.49 | 32.6 % |
| Q4 | Mar 26, 2026 | $-0.41 | $-0.53 | 22.6 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.40 | $-0.40 | $-0.49 | $-0.53 |
| Actual | $-0.35 | $-0.45 | $-0.33 | $-0.41 |
| Surprise | +12.5% | -12.5% | +32.6% | +22.6% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | — | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.46 | $-0.28 |
| Revenue | ||
| Consensus | — | — |
